论文部分内容阅读
大连美罗国际生物科技有限公司(以下简称“美罗国际”)成立于2005年1月18日,前身为慧力生物有限公司,后被大连美罗药业收归旗下,是美罗药业“试水”直销的重大举措。大连美罗药业是一家专业从事药品和保健品制造、流通的大型现代化企业集团,2000年在上海证券交易所以4.000万 A 股上市,总资产8.71亿元,净资产6.26亿元,拥有15家分公司、9家子公司和2个药物研究院。而新组建的美罗国际,注册资金1.165万元。是一家集生活用品、生物保健品、特殊营养食品等专项产品的科研、开发、生产、销售、服务于一体
Founded in January 18, 2005, Dalian Merro International Biotech Co., Ltd. (hereinafter referred to as “Merro International”), formerly known as Hui Li Bio Co., Ltd., was renamed as Metro Luo Pharmaceutical Co., Ltd. “Test the water” a major move direct. Dalian Merlot Pharmaceuticals is a large-scale modern enterprise group specialized in the manufacture and circulation of medicines and health products. It was listed on the Shanghai Stock Exchange with 40,000 A shares in 2000 with total assets of 871 million yuan and net assets of 626 million yuan, with 15 Branch offices, nine subsidiaries and two drug research institutes. The newly formed Merro International, a registered capital of 11,650 yuan. Is a collection of daily necessities, biological health products, special nutrition food and other special products research, development, production, sales and service in one